Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 288,706 |
|
|||||
| News | - | ||||||
| Day High | 9.61 | Low High |
|||||
| Day Low | 9.05 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Fennec Pharmaceuticals Inc | FENC | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.14 | -1.49% | 9.24 | 17:38:29 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 9.50 | 9.05 | 9.61 | 9.24 | 9.38 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 2,025 | 288,706 | $ 9.24 | $ 2,668,897 | - | 6.30 - 11.92 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:00:00 | 7,290 | $ 9.24 | USD |
Fennec Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 340.9M | 26.63M | - | 21.25M | -16.05M | -0.60 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Fennec Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical FENC Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 10.26 | 10.52 | 9.05 | 9.62 | 163,767 | -1.02 | -9.94% |
| 1 Month | 10.97 | 11.37 | 9.05 | 10.42 | 128,056 | -1.73 | -15.77% |
| 3 Months | 9.82 | 11.49 | 8.59 | 10.13 | 130,812 | -0.58 | -5.91% |
| 6 Months | 6.72 | 11.92 | 6.55 | 9.75 | 125,291 | 2.52 | 37.50% |
| 1 Year | 7.66 | 11.92 | 6.30 | 9.08 | 112,861 | 1.58 | 20.63% |
| 3 Years | 6.89 | 11.92 | 3.8219 | 7.93 | 101,644 | 2.35 | 34.11% |
| 5 Years | 4.48 | 11.92 | 3.255 | 7.50 | 114,567 | 4.76 | 106.25% |
Fennec Pharmaceuticals Description
| Fennec Pharmaceuticals Inc is a clinical-stage biotechnology company. It is primarily engaged in research and development activities. The company is developing Sodium Thiosulfate (STS), a chemo-protectant against hearing loss associated with platinum-based chemotherapy. Its lead product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin induced hearing loss, or ototoxicity in children. |
